Testing effectiveness (Phase 2)Study completedNCT01248884
What this trial is testing
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744)
Who this might be right for
TetanusPoliomyelitisHepatitis B+3 more
GlaxoSmithKline 721